Home
Ikarian Capital reported a 4.8% stake in Relmada Therapeutics RLMD · 3,543,359 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 4.8%
- Last report
- First report
- Shares held
- 3,543,359 sh
- Class
- Common Stock, par value $0.001 par value per share
- Holder
- Ikarian Capital
- Event date
- 25/09/30
- Filed
- 25/11/14
4.8% stake · below 5%
Relmada Therapeutics trades, last 26 weeks
What else happened in Relmada Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Ikarian Capital's other 5% stake reports
- Ikarian Capital
5% stakeCNS Pharmaceuticals
5% stakeCNS Pharmaceuticals
CNSP
9.9% stake
147,290 sh
9.9% stake
Filed 08/14
- Ikarian Capital
5% stakeConnect Biopharma Holdings
5% stakeConnect Biopharma Holdings
CNTB
6.9% stake
4,338,534 sh
6.9% stake
Filed 08/14
- Ikarian Capital
5% stakeQuince Therapeutics
5% stakeQuince Therapeutics
QNCX
9% stake
91,789 sh
9% stake
Filed 08/14
- Ikarian Capital
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
2.9% stake
1,080,700 sh
2.9% stake
Filed 08/14
- Ikarian Capital
5% stakeInMed Pharmaceuticals
5% stakeInMed Pharmaceuticals
INM
4.2% stake
137,634 sh
4.2% stake
Filed 08/14
